1144 MHC II neoantigen vaccines improve antitumor immunity and response to immune checkpoint inhibitor in cold tumor

1144 MHC II neoantigen vaccines improve antitumor immunity and response to immune checkpoint inhibitor in cold tumor

Bibliographic Details
Main Authors:	Yue Wang, Wei Liu, Jia Wei, Tao Shi, Yuting Luo, Xueru Song, Chun Lu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
by: David Repáraz, et al.
Published: (2022-02-01)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
by: Xue-lin Zou, et al.
Published: (2021-12-01)

A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
by: Hongwei Cheng, et al.
Published: (2022-06-01)

Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation
by: Paula Chiarella, et al.
Published: (2018-01-01)

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens
by: Luhui Shen, et al.
Published: (2023-05-01)

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
by: Da Zhang, et al.
Published: (2021-03-01)

Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
by: Wenhui Liu, et al.
Published: (2021-02-01)

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
by: Irantzu Anzar, et al.
Published: (2023-09-01)

Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune “cold” tumors
by: Guixiu Xiao, et al.
Published: (2023-10-01)

Advances in Synergistic Antitumor Effects of Radiopharmaceuticals Combined with Immune Checkpoint Inhibitors
by: ZENG Xinying, et al.
Published: (2023-07-01)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
by: Zhe Jing, et al.
Published: (2022-08-01)

Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors
by: Schramme, F, et al.
Published: (2019)

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
by: Chloé Grasselly, et al.
Published: (2018-10-01)

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope
by: Adam M. Swartz, et al.
Published: (2021-01-01)

Immune checkpoint: The novel target for antitumor therapy
by: Xianghu Jiang, et al.
Published: (2021-01-01)

In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
by: Veronique Beiss, et al.
Published: (2022-12-01)

The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy
by: Lidy Vannessa Mejía-Guarnizo, et al.
Published: (2023-12-01)

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
by: Wanzun Lin, et al.
Published: (2023-01-01)

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
by: E. V. Shubnikova, et al.
Published: (2020-03-01)

Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma
by: Yingying Bao, et al.
Published: (2022-07-01)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
by: Lijin Li, et al.
Published: (2021-04-01)

Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
by: Peng Ouyang, et al.
Published: (2024-03-01)

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
by: Joseph S. Dolina, et al.
Published: (2023-09-01)

Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
by: Xuewei Bai, et al.
Published: (2022-04-01)

Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
by: Shih-Cheng Pao, et al.
Published: (2022-04-01)

Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
by: Iker Malaina, et al.
Published: (2023-05-01)

ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma
by: Wengang Zhang, et al.
Published: (2022-12-01)

Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity
by: Juan Yang, et al.
Published: (2021-08-01)

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
by: Adrià Archilla-Ortega, et al.
Published: (2022-02-01)

Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
by: Jing Yu, et al.
Published: (2022-08-01)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
by: Lopes, A, et al.
Published: (2018)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
by: Alessandra Lopes, et al.
Published: (2018-10-01)

Tumour-immune dynamics with an immune checkpoint inhibitor
by: Elpiniki Nikolopoulou, et al.
Published: (2018-06-01)

LPCN 1144 Resolves NAFLD in Hypogonadal Males
by: Somaya Albhaisi, et al.
Published: (2020-10-01)

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy
by: Peng Jiang, et al.
Published: (2021-11-01)

Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression
by: Stefano Pierini, et al.
Published: (2021-02-01)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
by: Xi Chen, et al.
Published: (2022-04-01)

Immune Checkpoint Inhibitors and the Heart
by: Diana Larisa Mocan-Hognogi, et al.
Published: (2021-09-01)

FcγRIIB is a T cell checkpoint in antitumor immunity
by: Clara R. Farley, et al.
Published: (2021-02-01)